期刊文献+

shRNA干扰VEGF的表达对宫颈癌SiHa细胞凋亡的影响 被引量:7

Inhibition of VEGF expression by shRNA and effect on the apoptosis of cervical cancer SiHa cell line
下载PDF
导出
摘要 目的利用RNA干扰技术抑制S iHa细胞中血管内皮生长因子(VEGF)的基因表达,探讨其对肿瘤细胞凋亡的诱导作用。方法设计针对VEGF的两种短发夹RNA(shRNA),分别构建PGPU6/GFP/Neo-VEGF重组质粒表达载体,命名为pv1、pv2。利用脂质体将质粒转染入人宫颈癌S iHa细胞,采用RT-PCR方法检测VEGF mRNA的变化情况。筛选出抑制率较高的质粒进行下一步实验;转染后,用流式细胞术检测细胞凋亡。结果 pv1、pv2对VEGF mRNA均有显著的抑制作用,抑制率分别为(82.17±4.45)%和(64.55±3.80)%,显著高于阴性对照组的(7.63±4.13)%(P<0.05)。pv1转染组的细胞凋亡率为(47.85±4.65)%,明显高于阴性对照组的(17.76±2.12)%和空白对照组的(19.66±3.74)%(P<0.01)。结论 RNA干扰技术可以有效沉默人宫颈癌细胞株S iHa中VEGF mRNA的表达,并可诱导宫颈癌细胞凋亡。 Objective To study the induction of apoptosis by RNA interference-mediated inhibition of VEGF expression in SiHa cells.Methods Two types of short hairpin RNA were designed and prepared.The recombinant plasmid PGPU6/GFP/Neo-VEGF were constructed respectively,named pv1 and pv2,which were transfected into SiHa cells using LipofectamineTM 2000.RT-PCR was performed to detect the expression of VEGF mRNA.The most efficient shRNA was selected according to the expression of VEGF mRNA.The cell apoptosis was studied by flow cytometry.Results pv1 and pv2 inhibited the expression of VEGF mRNA in transfected group,and inhibition rates were(82.17±4.45)% and(64.55±3.80)% respectively,with significant differences from that in the negative control group(P0.05).The apoptosis rate of SiHa cells in pv1 group was(47.85±4.65)%,which was higher than that in negative control group(17.76±2.12)% and in blank control group(19.66±3.74)%,showing significant differences(P0.01).Conclusion RNAi technology can silence the expression of VEGF mRNA in SiHa cells and induce apoptosis,suggesting that the technology may be an effective therapy in cervical cancer.
作者 魏星 邢丽娜
出处 《临床肿瘤学杂志》 CAS 2011年第5期385-388,共4页 Chinese Clinical Oncology
基金 哈尔滨市科技攻关计划资助项目(2005AA9CS116-10)
关键词 短发夹RNA VEGF 宫颈癌 SIHA细胞 凋亡 Short hairpin RNA(shRNA) VEGF Cervical cancer SiHa cells Apoptosis
  • 相关文献

参考文献10

  • 1Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005,55(2) :74 - 108.
  • 2Folkman J. Tumor angiogenesis : therapeutic implications [ J ]. N Engl J Med,1971,285(21 ) :1182 -1186.
  • 3Connolly DT, Olander JV, Heuvelman D, et al. Human vascular permeability factor. Isolation from U937 cells[ J]. J Biol Chem, 1989,264(33 ) :20017 - 20024.
  • 4Elbashir SM, Harborth J, Weber K, et al. Analysis of gene function in somatic mammalian cells using small interfecting RNAs [J]. Methods,2002,26(2) :199 -213.
  • 5Lee IJ, Park KR, Lee KK, et al. Prognostic value of vascular endothelial growth factor in stage I B carcinoma of the uterine cervix [ J ]. Int J Radiat Oncol Biol Phys,2002,54 ( 3 ) :768 - 779.
  • 6徐平平,纪新强,张奎美.APE、VEGF在宫颈癌组织中的表达及其与MVD的关系[J].现代医学,2008,36(6):389-393. 被引量:7
  • 7Fujiwaki R, Hata K, Iida K, et al. Vascular endothelial growth factor expression in progression of cervical cancer: correlation with thymidine phosphorylase expression, angiogenesis, tumor cell proliferation, and apoptosis [ J ]. Anticancer Res, 2000,20 ( 2B ) : 1317 - 1322.
  • 8Kodama J, Seki N, Tokumo K, et al. Vascular endothelial growth factor is implicated in early invasion in cervical cancer[ J ]. Eur J Cancer, 1999,35 ( 3 ) :485 - 489.
  • 9Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans [ J ]. Nature, 1998,391 (6669) :806 - 811.
  • 10Sano D, Kawakami M, Fujita K, et al. Antitumor effects of ZD6474 on head and neck squamous cell carcinoma [ J ]. Oncol Rep ,2007,17 (2) :289 - 295.

二级参考文献15

  • 1Koukourakis M I,Giatromanolaki A,Kakolyris S,et al.Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome[J].Int J Radiat Oncol Biol Phys,2001,50(1):27-36.
  • 2Kakolyris S,Kaklamanis L,Engels K,et al.Human AP endonuclease 1 (HAP1) protein expression in breast cancer correlates with lymph node status and angiogenesis[J].Br J Cancer,1998,77(7):1169-1173.
  • 3Kakolyris S,Kaklamanis L,Engels K,et al.Human apurinic endonuclease 1 expression in a colorectal adenoma-carcinoma sequence[J].Cancer Res,1997,57 (9):1794-1797.
  • 4Kaio E,Tanaka S,Kitadai Y,et al.Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma[J].Oneology,2003,64(1):61273.
  • 5Furudoi A,Tavaka S,Haruma K,et al.Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma[J].Oneology,2002,62(2):157-166.
  • 6Wang D,Meihua L,Mark K B.Human apurinic endonuclease 1 (APE1) expressiong and prognostic significance in osteosarcoma:enhanced sensitivity of esteesarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition[J].Mol Cancer Ther,2004,3 (6):679-686.
  • 7Weidner N.Intratumor microvessel density as a prognostic factor in cancer[J].Am J Pathol,1995,147(1):9-19.
  • 8Puglisi F,Barbone F,Tell G,et al.Prognostic role of Ape/Bef1 subcellar expression in stage Ⅰ-Ⅲ breast carcinomas[J].Oncol Bep,2002,9(1):11-17.
  • 9Parsons J L,Dianova I I,Dianov G L.APE1 is the major 3' phosphoglycolate activity in human cell extracts[J].Nucleic Acids Res,2004,32(12):3531-3536.
  • 10Wong D,Demple B.Modulation of the 5'-deoxyribose-5-phosphatelyase and DNA synthesis activities of mammalian DNA polymerasebeta by apurinic/apyrimidinic endonuclease 1[J].J Biol Chem,2004,279 (24):25268-25275.

共引文献6

同被引文献96

引证文献7

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部